The Early Drug Development Program oversees research dedicated to studying new drugs that may become effective treatments for cancer. They conduct phase I clinical trials that are carefully designed safety studies of experimental drugs being given to patients for the first time.
Assistant Director, Development and Experimental Therapeutics
Paul Eder, MD
Research Scientist, Developmental and Experimental Therapeutics
Juliane M. Jürgensmeier, PhD